References
- Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51:241–248.
- Hornberger J, Grimes K, Naumann M, Glaser DA, Lowe NJ, Naver H, Ahn S, Stolman LP. Recognition, diagnosis, and treatment of primary focal hyperhidrosis. J Am Acad Dermatol. 2004;52:274–286.
- Naumann M, Hamm H, Lower NJ. Effect of botulinum toxin type A on quality- of life measures in patients with excessive axillary sweating: a randomised controlled trial. Br J Dermatol. 2002;147:1218–1226.
- Swartling C, Naver H, Lindberg M. Botulinum A toxin improves quality of life in severe primary focal hyperhidrosis. Eur J Neurol. 2001;8:247–252.
- Cina CS, Clase CM. The illness intrusiveness rating scale: a measure of severity in individuals with hyperhidrosis. Qual Life Res. 1999;8:693–698.
- Eisench JH, Atkinson JLD, Fealey RD. Hyperhidrosis: evolving therapies for a well-established phenomenon. Mayo Clin Proc. 2005;80:824–828.
- Grice K, Sattar H, Baker H. Treatment of idiopathic hyperhidrosis with iontophoresis of tap water and polodine methosulphate. Br J Dermatol. 1972;86:72–78.
- Karakoc Y, Aydemir EH, Kalkan T, Unal G. Safe control of palmoplantar hyperhidrosis with direct electrical current. Int J Dermatol. 2002;41:602–605.
- Reinauer S, Neusser A, Schauf G, Holzle E. Iontophoresis with alternating current and direct offset (AC/DC iontophoresis): a new approach for the treatment of hyperhidrosis. Br J Dermatol. 1993;129:166–169.
- Akins DL, Meisenheimer JL, Dobson RL. Efficacy of drionic unit in the treatment of hyperhidrosis. J Am Acad Dermatol. 1987;16:828–832.